Covid 19
CORONAVIRUS RESOURCE CENTER
CORONAVIRUS RESOURCE CENTER
Jump to irritable bowel syndrome (IBS) Crohn’s disease celiac disease chronic liver disease diabetes leaky gut syndrome Cirrhosis of the liver describes a condition where scar tissue gradually replaces healthy liver cells. It is a progressive disease, developing slowly over many years. If it is allowed to continue, the buildup of scar tissue can eventually […]
A preliminary clinical trial shows that stem cell transplantation, along with a tolerable dose of chemotherapy, is safe and more effective at slowing down multiple sclerosis than other existing therapies. Scientists were able to slow down MS progression in a new clinical trial using stem cell transplantation. Multiple sclerosis (MS) is a chronic neurodegenerative condition […]
Integrase inhibitors give greater chance of viral suppression at delivery in pregnant women Jump to Raltegravir-based ART started in pregnancy Dolutegravir-based ART started in late pregnancy References Integrase inhibitor-based treatment with either raltegravir (Isentress) or dolutegravir (Tivicay, also in Triumeq) reduces viral load more rapidly than efavirenz if started in pregnancy, findings from two randomised […]
The key difference between polycythemia and erythrocytosis is that polycythemia refers to the condition in which both red blood cells and haemoglobin increase above the normal level while erythrocytosis refers to the condition where the red blood cell mass increases beyond the normal level. Polycythemia and Erythrocytosis occur when there are abnormal levels of red […]
HIV-positive participant in vaccine study passes virus to sexual partner during treatment interruption An HIV-positive man transmitted HIV to his sexual partner after interrupting antiretroviral therapy as part of a research study into a therapeutic vaccine, French scientists reported in the Journal of Infectious Diseases last week. The case report underlines the importance of participants […]
Craig Hendrix at HIVR4P 2018. Photo by Roger Pebody. Gus Cairns Published: 09 November 2018 Difference “equivalent to four days of PrEP per week rather than seven” A study presented at last month’s HIV Research for Prevention conference (HIVR4P) in Madrid shows that transgender women who are taking feminising hormones and also taking pre-exposure prophylaxis […]